User:Hamidelectronics

Carpal Tunnel Release Through Mini Transverse Approach (CTRMTA)

Sayed Issa's Approach NCT Identifier: NCT02766114

Abdulhamid Sayed Issa, M.D.

May 6, 2016

First Received: May 4, 2016

Last Updated: May 6, 2016

Phase: N/A

Start Date: February 2013

Overall Status: Completed

Estimated Enrollment: 43

Overview

Carpal tunnel release through dorsal wrist crease Mini Transverse incision, about 1.5 cm length.

Study Type


 * Study Type: Interventional

Intervention Model: Single Group Assignment Primary Purpose: Treatment Masking: Open Label
 * Study Design


 * Study Primary Completion Date: March 2016

Detailed Description

Carpal tunnel release through a small approach on the distal wrist crease, it is about 1.5 cm, the benefits of this technique is less surgical traumatic and more tender, it takes less time for rehabilitation, so the patient can work next day of operation, and it has very cosmetic and gentle scar in results and outcome.

Interventions

Procedure: Carpal tunnel release through Mini Transverse Approach Carpal tunnel release through a transverse cosmetic small incision over the distal wrist crease.

Arms, Groups and Cohorts

After local anesthesia, through transverse approach on the middle of dorsal wrist crease the incision is made for 1.5 cm length, then the subcutaneous fat is dissected, soon we see the the palmaris longus tendon or its connection with the carpal ligament, take the ulnar side of the palmaris longus tendon and cut the carpal ligament axillary by scalpel, not going deep with the scalpel to avoid medial nerve injury, soon we see the nerve, we use the scissors to cut the proximal part then the distal part of the carpal ligament by enclosing it between the blades of the scissors, now the full released carpal tunnel most be observed, and one stitch is enough, in this operation most be an assistant exist.
 * Experimental: Issa1

Clinical Trial Outcome Measures


 * Primary Measures

Proportion of patients with post surgical trauma Time Frame: Up to eight weeks


 * Secondary Measures

Duration of rehabilitation period Time Frame: Up to three weeks Proportion of patients with cosmetic scar Time Frame: Up to 6 months Participating in This Clinical Trial

Inclusion Criteria

Patients presented with Carpal Tunnel Syndrome refractory to conservative treatment Participant cooperation sufficient to operate under local anesthesia

Exclusion Criteria

Un controlled diabetes mellitus type 1 and 2 Patients with non controlled Vascular hypertension Significant renal disease, defined as a history of chronic renal failure requiring dialysis or kidney transplant. Myocardial infarction, other acute cardiac event requiring hospitalization, stroke, transient ischemic attack, or treatment for acute congestive heart failure within 4 months prior to randomization Patients with history of Carpal Tunnel release surgery failure Gender Eligibility: All

Minimum Age: 16 Years

Maximum Age: 70 Years

Are Healthy Volunteers Accepted: No

Investigator Details

Lead Sponsor Issa, Abdulhamid Sayed, M.D. Provider of Information About this Clinical Study Sponsor

'''https://trialbulletin.com/lib/entry/ct-02766114 '''

NCT02766114
 * 1) Sayed Issa's Approach
 * 2) NCT02766114
 * 3) March 31, 2017
 * 4) Issa, Abdulhamid Sayed, M.D.
 * 5) ClinicalTrials.gov Identifier:
 * 1) Carpal Tunnel Release Through Mini Transverse Approach
 * 2) CTRMTA
 * 3) Carpal Tunnel Syndrome